[1] SONG P,FENG X,ZHANG K,et al.Screening for and surveillance of high-risk patients with HBV-related chronic liver disease:promoting the early detection of hepatocellular carcinoma in China[J].Bioscience Trends,2013,7(1):1-6.
[2] ANWAR S L,LEHMANN U.DNA methylation,microRNAs,and their crosstalk as potential biomarkers in hepatocellular carcinoma[J].World J Gastroenterol,2014,20(24):7894-7913.
[3] 高丽丽,余卫平.PLMT家族成员SET7/9的非组蛋白甲基化作用[J].生命科学,2011,23(8):773-778.
[4] NISHIOKA K,CHUIKOY S,SARMA K,et al.Set9,a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation[J].Genes Dev,2002,16(4):479-489.
[5] 汪渊.蛋白甲基化修饰酶SET7/9对p53缺失人肺癌细胞的凋亡效应及其机制[D].南京:东南大学,2014.
[6] ZHOU J,XIE M,SHI Y,et al.MicroRNA-153 functions as a tumor suppressor by targeting SET7 and ZEB2 in ovarian cancer cells[J].Oncology Reports,2015,34(1):111-120.
[7] SONG Y,ZHANG J,TIAN T,et al.SET7/9 inhibits oncogenic activities through regulation of Gli-1 expression in breast cancer[J].Tumor Biol,2016,37(7):1-12.
[8] KURASH J K,LEI H,SHEN Q,et al.Methylation of p53 by Set7/9 mediates p53 acetylation and activity in vivo[J].Molecular Cell,2008,29(3):392-400.
[9] MUNRO S,KHAIRE N,INCHE A,et al.Lysine methylation regulates the pRb tumour suppressor protein[J].Oncogene,2010,29(16):2357-2367.
[10] YOSHIMITSU A,YUKI K,SUN-JU B,et al.Reduced expression of SET7/9,a histone mono-methyltransferase,is associated with gastric cancer progression[J].Oncotarget,2015,7(4):3966-3983. |